The Role of SGLT 2 Inhibitor in the Therapy of Obesity
Published: 2023-07-09
Page: 104-114
Issue: 2023 - Volume 6 [Issue 1]
Giovanno Sebastian Yogie *
Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia.
Darren Gosal
Faculty of Medicine, Hasanuddin University, Makasar, Indonesia.
Yohanes Firmansyah
Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia.
Alexander Halim Santoso
Department of Clinical Nutrition, Tarumanagara University, Jakarta, Indonesia.
*Author to whom correspondence should be addressed.
Abstract
Obesity is an abnormal or excessive fat accumulation that presents a risk to health, including hypertension, stroke, kidney disease, atherosclerosis, type 2 diabetes mellitus, heart disease, and sleep apnea. Obesity can be caused by various aetiology, such as genetics, lifestyle, psychology, treatment, and more. Treatment of obesity is needed to prevent these further complications. According to various studies, SGLT 2 inhibitor has shown effectiveness in losing weight. This review article aims to describe the effectiveness and safety of SGLT 2 inhibitors in the treatment of obesity. It is expected SGLT 2 inhibitor can be considered in the administration of therapy in patients with obesity.
Keywords: Obesity, SGLT 2 inhibitor, weight loss